Austin W. Marxe & David M. Greenhouse’s Arbutus Biopharma ABUS Stock Holding History

Austin W. Marxe & David M. Greenhouse’s Portfolio ABUS Stock Details ABUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$3.7M	Sell	175,000 -295,595	-63%	-$4.83M	0.5%	62
2014 Q2	$6.15M	Buy	470,595 +50,033	+12%	+$709K	0.78%	47
2014 Q1	$9.04M	Buy	420,562 +175,000	+71%	+$3.14M	1%	32
2013 Q4	$1.96M	Buy	245,562 +211,292	+617%	+$1.76M	0.21%	91
2013 Q3	$239K	Buy	+34,270	New	+$189K	0.03%	123

Other funds holding ABUS

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Austin W. Marxe & David M. Greenhouse's ABUS Position: Q3 2014 in Review

Austin W. Marxe & David M. Greenhouse reduced its Arbutus Biopharma (ABUS) stake by 63% in Q3 2014, selling an estimated $4.83M and leaving 175,000 shares worth $3.7M. The position accounts for 0.5% of the portfolio, ranked #62.

Austin W. Marxe & David M. Greenhouse first reported a position in ABUS in Q3 2013 and has held it in 5 quarters since. The position peaked at $9.04M in Q1 2014. 48 funds tracked by Wall St. Rank hold ABUS as of Q3 2014.

Austin W. Marxe & David M. Greenhouse held 175,000 shares of Arbutus Biopharma worth $3.7M as of Q3 2014.
Austin W. Marxe & David M. Greenhouse sold 295,595 Arbutus Biopharma shares in Q3 2014, an estimated $4.83M.
Arbutus Biopharma made up 0.5% of Austin W. Marxe & David M. Greenhouse's portfolio in Q3 2014, its #62 holding.
Austin W. Marxe & David M. Greenhouse first reported a position in Arbutus Biopharma in Q3 2013 and has held it in 5 quarters since.
Austin W. Marxe & David M. Greenhouse's Arbutus Biopharma position peaked at $9.04M in Q1 2014.
48 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q3 2014.

Based on Austin W. Marxe & David M. Greenhouse's 13F filing for Q3 2014, filed 14 Nov 2014.